Clarus Therapeutics Holdings, Inc. (CRXT): Price and Financial Metrics

Clarus Therapeutics Holdings, Inc. (CRXT): $0.05

0.02 (-31.16%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

C

Add CRXT to Watchlist
Sign Up

CRXT Price/Volume Stats

Current price $0.05 52-week high $10.57
Prev. close $0.07 52-week low $0.05
Day low $0.05 Volume 2,737,100
Day high $0.07 Avg. volume 6,391,756
50-day MA $0.29 Dividend yield N/A
200-day MA $1.30 Market Cap 2.47M

CRXT Stock Price Chart Interactive Chart >


Clarus Therapeutics Holdings, Inc. (CRXT) Company Bio


Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.


CRXT Latest News Stream


Event/Time News Detail
Loading, please wait...

CRXT Latest Social Stream


Loading social stream, please wait...

View Full CRXT Social Stream

CRXT Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!